Objective:To observe the targeting proapoptotic effect of expression vector containing AFPregulation sequence on AFP positive hepatoma cells. Methods: AFP promoter, silencer and the most remote enhancer Ⅲ were ligated to construct a 12 kb AFP regulation sequence, which was then used to construct a pAFPEGFP plasmid. The pAFPEGFP was used to transfect human hepatoma HepG2 (AFP positive), human hepatoma SMMC7721 (AFP negative) and human cervical carcinoma HeLa (AFP negative) cells; the fluorescent protein expression intensities were observed under fluorescence microscope. A pAFPP53EGFP plasmid was further constructed by inserting P53 gene into pAFPEGFP, which was then transfected into HepG2, SMMC7721 and HeLa cells. P53 protein expressions were detected by Western blotting analysis in different groups; apoptosis rates and cell cycles were examined by flow cytometry. Results: pAFPEGFP and pAFPP53EGFP recombinant plasmids were successfully constructed. The expression of EGFP fluorescent protein in pAFPEGFPtransfected AFP positive HepG2 cells was significant higher than those in AFP negative SMMC7721 and HeLa cells; P53 protein expression in HepG2 cells transfected with pAFPP53EGFP was also significantly higher than those in SMMC7721 and HeLa cells. The G1 phase proportion and apoptosis rate of pAFPP53EGFPtransfected HepG2 cells were significantly higher than those of SMMC7721 and HeLa cells (\[66.7±0.25\]% vs \[50.5±0.18\]%, \[51.0±020\]%, P<0.05; \[2.65±0.08\]% vs \[0.42±0.03\]%, \[0.39±0.02\]%, P<0.05), but S phase proportion of pAFPP53EGFPtransfected HepG2 cells was significantly lower than those of SMMC7721 and HeLa cells (\[20.1±022\]% vs \[29.8±0.18\]%, \[37.8±0.21\]%, P<0.05). Conclusion: The pAFPP53EGFP plasmid containing AFP regulation sequence can specifically target AFP positive hepatoma cells, inducing cell cycle arrest and apoptosis of hepatoma cells.